Dr Channa Hewamadduma is a consultant neurologist with specialist interest in neuromuscular disorders at Sheffield Teaching Hospitals Foundation Trust (STHFT) and an Honorary Senior Lecturer at the University of Sheffield. He completed his PhD in neuro-genetics in Motor neuron disease, funded by a prestigious MRC Clinical Training Fellowship under Professor Dame Pamela Shaw. He conducts a portfolio of clinical and basic science research in neuro-genetics and neuro-inflammatory disorders in SITRAN (Sheffield Institute for Translational Neurosciences) and at STHFT. He is also the co-chair of the South Yorkshire and Humber neuromuscular network. Dr Hewamadduma is the lead clinician of the neuromuscular service at STHFT and runs the regional myasthenia gravis referral service for Rituximab and Efgartigimod. Dr Hewamadduma conducts a portfolio of clinical trials in myasthenia gravis in addition to other NM disorders. Investigating new therapies and understanding how diseases progress using biomarkers and patient reported outcomes (PROMS) are his key focusses. He is a member of the NICE/NHSE advisory panel on SMA related therapies and an invited clinical expert in NICE appraisal of therapies in myasthenia gravis. He enjoys teaching and set up the Myasthenia gravis master class to help teach clinicians, neurology trainees and allied health professionals. He enjoys gardening with a particular interest in Acers and traveling, especially off the beaten track.